Lisa Greenbaum Biography and Net Worth

EVP of Progyny

Lisa is responsible for all commercial activities at Verily including sales, business development, alliance management, and sales operations. Lisa has spent over 25 years in the healthcare industry. Most recently she was the Chief Client Officer at Progyny, a fertility benefits management company. Prior to that, Lisa spent 15 years at WebMD where she was Group General Manager of the Medscape Professional Services and led sales, account management, product marketing and revenue delivery. Lisa has also held senior sales roles in the digital health and pharma space at HealthStream, Merck, and Procter & Gamble.

What is Lisa Greenbaum's net worth?: The estimated net worth of Lisa Greenbaum is at least $252,027.30 as of April 15th, 2021. Ms. Greenbaum owns 16,746 shares of Progyny stock worth more than $252,027 as of October 31st. This net worth approximation does not reflect any other assets that Ms. Greenbaum may own. Learn More about Lisa Greenbaum's net worth.
How do I contact Lisa Greenbaum?: The corporate mailing address for Ms. Greenbaum and other Progyny executives is 1359 BROADWAY, NEW YORK NY, 10018. Progyny can also be reached via phone at 212-888-3124 and via email at [email protected]. Learn More on Lisa Greenbaum's contact information.
Has Lisa Greenbaum been buying or selling shares of Progyny?: Lisa Greenbaum has not been actively trading shares of Progyny over the course of the past ninety days. Most recently, Lisa Greenbaum sold 2,353 shares of the business's stock in a transaction on Thursday, April 15th. The shares were sold at an average price of $50.46, for a transaction totalling $118,732.38. Following the completion of the sale, the executive vice president now directly owns 16,746 shares of the company's stock, valued at $845,003.16. Learn More on Lisa Greenbaum's trading history.
Who are Progyny's active insiders?: Progyny's insider roster includes Peter Anevski (COO), Jennifer Bealer (EVP), Kevin Gordon (Director), Lisa Greenbaum (EVP), Mark Livingston (CEO), Norman Payson (Director), David Schlanger (CEO), Cheryl Scott (Director), and Michael Sturmer (President). Learn More on Progyny's active insiders.
Are insiders buying or selling shares of Progyny?: In the last twelve months, insiders at the sold shares 21 times. They sold a total of 435,631 shares worth more than $16,218,883.10. The most recent insider tranaction occured on July, 16th when President Michael E Sturmer sold 9,030 shares worth more than $270,900.00. Insiders at Progyny own 12.3% of the company. Learn More about insider trades at Progyny.
Information on this page was last updated on 7/16/2024.

Lisa Greenbaum Insider Trading History at Progyny

Transaction Date	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
4/15/2021	Sell	2,353	$50.46	$118,732.38	16,746
3/15/2021	Sell	3,032	$48.69	$147,628.08	16,746
2/16/2021	Sell	3,046	$51.00	$155,346.00	10,044
1/15/2021	Sell	2,846	$44.44	$126,476.24	10,044
11/9/2020	Sell	1,772	$29.98	$53,124.56	9,044
10/26/2020	Sell	873	$27.39	$23,911.47	7,044
9/30/2020	Sell	11,646	$27.41	$319,216.86	21,044
9/24/2020	Sell	869	$26.77	$23,263.13	21,044
7/24/2020	Sell	9,005	$26.95	$242,684.75	21,044

Lisa Greenbaum Buying and Selling Activity at Progyny

Progyny Company Overview

Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York.

Today's Range

Now: $15.05

$14.98

$15.39

50 Day Range

MA: $18.88

$15.05

$24.82

2 Week Range

Now: $15.05

$13.93

$42.08

Volume

1,038,003 shs

Average Volume

1,376,043 shs

Market Capitalization

$1.36 billion

P/E Ratio

23.89

Dividend Yield

N/A

Beta

1.43

Election warning coming true…

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - watch it before it's too late.

Click here to watch it now.